AUPH
AUPH
CA05156V1022
Aurinia Pharmaceuticals Inc
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.22B EUR
2.26B EUR
1.94B EUR
2.11B EUR
Enterprise Value
1.78B EUR
2.14B EUR
1.97B EUR
2.11B EUR
Valuation Multiples
Trailing P/E
7.3x
7.18x
6.5x
8x
Forward P/E
15.61x
--
--
--
Price to Sales
7.11x
7.24x
6.5x
9.57x
Price to Book
3.6x
3.67x
3.41x
3.63x
EV/Revenue
5.71x
6.87x
6.59x
9.54x
EV/EBITDA
9.89x
11.64x
12.48x
19.53x
Price to FCF (P/FCF)
14.99x
12.88x
11.63x
15.74x
EV/FCF
12.04x
12.22x
11.8x
15.7x
FCF Yield
6.67%
7.76%
8.6%
6.35%
ende